Table 2.
Seven differentially expressed miRNAs between hypertension and control subjects in the discovery cohort.
| Mean of Normalized Counts | |||||
|---|---|---|---|---|---|
| miRNA | Control Group (n = 30) |
Hypertension Group (n = 30) |
Log2 FC | p | FDR |
| hsa-miR-186-5p | 9620 | 7314 | −0.410 | 0.0013 | 0.043 |
| hsa-miR-210-3p | 130 | 81 | −0.653 | 0.0012 | 0.041 |
| hsa-miR-361-3p | 3917 | 3113 | −0.344 | 0.0002 | 0.028 |
| hsa-miR-362-5p | 450 | 317 | −0.494 | 0.0002 | 0.028 |
| hsa-miR-378a-5p | 349 | 248 | −0.515 | 0.00005 | 0.018 |
| hsa-miR-501-5p | 26 | 18 | −0.503 | 0.0008 | 0.038 |
| hsa-miR-769-5p | 47 | 30 | −0.616 | 0.00003 | 0.015 |
FC indicates fold change; FDR—Benjamini–Hochberg false discovery rate.